To avoid this in the periphery, the anti-CD3 Fab is blocked until activation by linker cleavage through a tumor-specific protease site (matriptase, MMP-2 or MMP-9) that connects the mask and anti-CD3 Fab. This evidence concerns the gene ST14 and neoplasm.